Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Psychiatric Quarterly

19-04-2024 | Generalised Anxiety Disorder | Original Paper

Healthcare Utilization and Its Correlates in Comorbid Type 2 Diabetes Mellitus and Generalized Anxiety Disorder

Authors: Chun-Jen Huang, Ching-Hua Lin, Tai-Ling Liu, Pai-Cheng Lin, Chin-Chen Chu, Jhi‑Joung Wang, Chun-Wang Wei, Shih-Feng Weng

Published in: Psychiatric Quarterly

Login to get access

Abstract

This study investigated the healthcare utilization and medical expenditure of type 2 diabetes mellitus (T2DM) patients with generalized anxiety disorder (GAD) and identified the associated factors. The healthcare utilization and expenditure of T2DM patients with (case group) and without (control group) GAD between 2002 and 2013 were examined using the population-based Taiwan National Health Insurance Research Database. Healthcare utilization included outpatient visits and hospitalization; health expenditure included outpatient, inpatient, and total medical expenditure. Moreover, nonpsychiatric healthcare utilization and medical expenditure were distinguished from total healthcare utilization and medical expenditure. The average healthcare utilization, including outpatient visits and hospitalization, was significantly higher for the case group than for the control group (total and nonpsychiatric). The results regarding differences in average outpatient expenditure (total and nonpsychiatric), inpatient expenditure (total and nonpsychiatric), and total expenditure (total and nonpsychiatric) between the case and control groups are inconsistent. Sex, age, income, comorbidities/complications, and the diabetes mellitus complication severity index were significantly associated with outpatient visits, medical expenditure, and hospitalization in the case group (total and nonpsychiatric). Greater knowledge of factors affecting healthcare utilization and expenditure in comorbid individuals may help healthcare providers intervene to improve patient management and possibly reduce the healthcare burden in the future.
Literature
1.
Lin WH, Hsu CH, Chen HF, Liu CC, Li CY. Mortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study. Diabetes Res Clin Pract. 2015;107:178–86.PubMedCrossRef
2.
Holman N, Forouhi N, Goyder E, Wild S. The Association of Public Health Observatories (APHO) diabetes prevalence model: estimates of total diabetes prevalence for England, 2010–2030. Diabet Med. 2011;28:575–82.PubMedCrossRef
3.
Akena D, Kadama P, Ashaba S, Akello C, Kwesiga B, Rejani L, et al. The association between depression, quality of life, and the health care expenditure of patients with diabetes mellitus in Uganda. J Affect Disord. 2015;174:7–12.PubMedCrossRef
4.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.PubMedCrossRef
5.
Molosankwe I, Patel A, Gagliardino JJ, Knapp M, McDaid D. Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord. 2012;142:S42–55.PubMedCrossRef
6.
Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998;21(Suppl 3):C11–4.PubMedCrossRef
7.
Association AD. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296–309.CrossRef
8.
Barrera TL, Mott JM, Hundt NE, Mignogna J, Yu HJ, Stanley MA, et al. Diagnostic specificity and mental health service utilization among veterans with newly diagnosed anxiety disorders. Gen Hosp Psychiatry. 2014;36:192–8.PubMedCrossRef
9.
Maier W, Gänsicke M, Freyberger H, Linz M, Heun R, Lecrubier Y. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatr Scand. 2000;101:29–36.PubMedCrossRef
10.
Kujanpaa T, Ylisaukko-Oja T, Jokelainen J, Linna M, Timonen M. Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland. Nord J Psychiatry. 2014;68:306–10.PubMedCrossRef
11.
Hoffman DL, Dukes EM, Wittchen HU. Human and economic burden of generalized anxiety disorder. Depress Anxiety. 2008;25:72–90.PubMedCrossRef
12.
Chien IC, Wu EL, Lin CH, Chou YJ, Chou P. Prevalence of diabetes in patients with major depressive disorder: a population-based study. Compr Psychiatry. 2012;53:569–75.PubMedCrossRef
13.
Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349:1498–504.PubMedCrossRef
14.
Clarke PM, Glasziou P, Patel A, Chalmers J, Woodward M, Harrap SB, et al. Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med. 2010;7:1000236.PubMedPubMedCentralCrossRef
15.
Gulliford MC, Latinovic R, Charlton J. Diabetes diagnosis, resource utilization, and health outcomes. Am J Manag Care. 2008;14:32–8.PubMed
16.
Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care. 2002;25:482–6.PubMedCrossRef
17.
Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002;45:S13–7.PubMedCrossRef
18.
Huang CJ, Lin CH, Lee MH, Chang KP, Chiu HC. Prevalence and incidence of diagnosed depression disorders in patients with diabetes: a national population-based cohort study. Gen Hosp Psychiatry. 2012;34:242–8.PubMedCrossRef
19.
Huang CJ, Chiu HC, Lee MH, Wang SY. Prevalence and incidence of anxiety disorders in diabetic patients: a national population-based cohort study. Gen Hosp Psychiatry. 2011;33:8–15.PubMedCrossRef
20.
Hsu JH, Chien IC, Lin CH, Chou YJ, Chou P. Incidence of Diabetes in Patients With Schizophrenia: a Population-based Study. Can J Psychiatry. 2011;56:19–26.PubMedCrossRef
21.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.PubMedCrossRef
22.
Vamos EP, Mucsi I, Keszei A, Kopp MS, Novak M. Comorbid depression is associated with increased healthcare utilization and lost productivity in persons with diabetes: a large nationally representative Hungarian population survey. Psychosom Med. 2009;71:501–7.PubMedCrossRef
23.
Nichols L, Barton PL, Glazner J, McCollum M. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff Resour Alloc. 2007;5:4.PubMedPubMedCentralCrossRef
24.
Simon GE, Katon WJ, Lin EH, Ludman E, VonKorff M, Ciechanowski P, et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry. 2005;27:344–51.PubMedCrossRef
25.
Finkelstein EA, Bray JW, Chen H, Larson MJ, Miller K, Tompkins C, et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care. 2003;26:415–20.PubMedCrossRef
26.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25:464–70.PubMedCrossRef
27.
Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–85.PubMedCrossRef
28.
Huang CJ, Chiu HC, Hsieh HM, Yen JY, Lee MH, Chang KP, et al. Health care utilization and expenditures of persons with diabetes comorbid with anxiety disorder: a national population-based cohort study. Gen Hosp Psychiatry. 2015;37:299–304.PubMedCrossRef
29.
Huang C-J, Wang S-Y, Lee M-H, Chiu H-C. Prevalence and incidence of mental illness in diabetes: a national population-based cohort study. Diabetes Res Clin Pract. 2011;93:106–14.PubMedCrossRef
30.
Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14:15–23.PubMedPubMedCentral
31.
Chiu HC, Shi HY, Mau LW, Wang GJ. The effects of a prospective case payment system on hospital charges for total hip arthroplasty in Taiwan. J Arthroplasty. 2007;22:65–71.PubMedCrossRef
32.
Sullivan G, Han X, Moore S, Kotrla K. Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders. Psychiatr Serv. 2006;57:1126–31.PubMedCrossRef
33.
Garrison MM, Katon WJ, Richardson LP. The impact of psychiatric comorbidities on readmissions for diabetes in youth. Diabetes Care. 2005;28:2150–4.PubMedCrossRef
34.
Hutter N, Schnurr A, Baumeister H. Healthcare costs in patients with diabetes mellitus and comorbid mental disorders—a systematic review. Diabetologia. 2010;53:2470–9.PubMedCrossRef
35.
Black G, Roberts RM, Li-Leng T. Depression in rural adolescents: relationships with gender and availability of mental health services. Rural Remote Health. 2012;12:2092.PubMed
36.
Wang W, Fu C, Zhuo H, Luo J, Xu B. Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China. BMC Health Serv Res. 2010;10:244.PubMedPubMedCentralCrossRef
37.
Chaikledkaew U, Pongchareonsuk P, Chaiyakunapruk N, Ongphiphadhanakul B. Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals. Value Health. 2008;11:S69–74.PubMedCrossRef
38.
Rost K, Zhang M, Fortney J, Smith J, Smith GR Jr. Rural-urban differences in depression treatment and suicidality. Med Care. 1998;36:1098–107.PubMedCrossRef
39.
Su C-H, Chiu H-C, Hsieh H-M, Yen J-Y, Lee M-H, Li C-Y, et al. Healthcare Utilization and Expenditures for Persons with Diabetes Comorbid with Mental Illnesses. Psychiatr Q. 2016;87:545–57.PubMedCrossRef
40.
Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994;151(7):979–86.
41.
Jackson-Triche ME, Sullivan JG, Wells KB, Rogers W, Camp P, Mazel R. Depression and health-related quality of life in ethnic minorities seeking care in general medical settings. J Affect Disord. 2000;58:89–97.PubMedCrossRef
42.
Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(Suppl 5):S1-85.PubMed
43.
Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia. 2003;46:1190–8.PubMedCrossRef
44.
Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc. 2005;104:157–63.PubMed
45.
Liptzin B, Regier DA, Goldberg ID. Utilization of health and mental health services in a large insured population. Am J Psychiatry. 1980;137:553–8.PubMedCrossRef
Metadata
Title
Healthcare Utilization and Its Correlates in Comorbid Type 2 Diabetes Mellitus and Generalized Anxiety Disorder
Authors
Chun-Jen Huang
Ching-Hua Lin
Tai-Ling Liu
Pai-Cheng Lin
Chin-Chen Chu
Jhi‑Joung Wang
Chun-Wang Wei
Shih-Feng Weng
Publication date
19-04-2024
Publisher
Springer US
Published in
Psychiatric Quarterly
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-024-10072-z